Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-49,549
Closed -$3.39M 704
2025
Q4
$3.39M Sell
49,549
-17,694
-26% -$1.22M 0.02% 431
2025
Q3
$4.85M Sell
67,243
-16,873
-20% -$1.3M 0.03% 377
2025
Q2
$6.55M Buy
84,116
+33,180
+65% +$2.68M 0.04% 310
2025
Q1
$4.15M Buy
+50,936
New +$4.46M 0.03% 368
2023
Q2
Sell
-53,187
Closed -$2.85M 764
2023
Q1
$2.85M Buy
53,187
+29,070
+121% +$1.73M 0.02% 495
2022
Q4
$1.34M Sell
24,117
-5,221
-18% -$254K 0.01% 655
2022
Q3
$1.57M Buy
29,338
+14,966
+104% +$938K 0.01% 631
2022
Q2
$825K Sell
14,372
-83,308
-85% -$6.74M 0.01% 659
2022
Q1
$10.5M Buy
97,680
+21,521
+28% +$2.47M 0.07% 248
2021
Q4
$11.6M Buy
76,159
+18,400
+32% +$4.19M 0.07% 242
2021
Q3
$14.9M Sell
57,759
-5,255
-8% -$1.51M 0.1% 216
2021
Q2
$17.6M Buy
63,014
+49,606
+370% +$11.1M 0.12% 196
2021
Q1
$2.86M Hold
13,408
0.02% 464
2020
Q4
$2.98M Buy
13,408
+2,073
+18% +$466K 0.02% 475
2020
Q3
$2.44M Sell
11,335
-774
-6% -$161K 0.02% 470
2020
Q2
$2.08M Buy
+12,109
New +$1.53M 0.02% 479

Other funds holding DOCU

Candriam SCA's DOCU Position: Q1 2026 in Review

Candriam SCA sold out of DocuSign (DOCU) in Q1 2026, closing a stake of 49,549 shares — an estimated $3.39M sold.

Candriam SCA first reported a position in DOCU in Q2 2020 and held it in 16 quarters. The position peaked at $17.6M in Q2 2021. 707 funds tracked by Wall St. Rank hold DOCU as of Q1 2026.

  • Candriam SCA reported no remaining DocuSign position as of Q1 2026 after selling out during the quarter.
  • Candriam SCA sold 49,549 DocuSign shares in Q1 2026, an estimated $3.39M.
  • Candriam SCA first reported a position in DocuSign in Q2 2020 and held it in 16 quarters.
  • Candriam SCA's DocuSign position peaked at $17.6M in Q2 2021.
  • 707 funds tracked by Wall St. Rank held DocuSign as of Q1 2026.

Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.